BRC Consultant in Paediatrics and Vaccinology.
- Honorary Senior Clinical Lecturer
Vaccines and vaccine preventable disease in childhood
I am a BRC funded consultant in paediatrics and vaccinology. I undertook clinical training in paediatrics in Oxford, Reading, Melbourne, Vancouver and Yorkshire. I completed a PhD in 2008 within the Oxford Vaccine Group and began my current post in 2009. I divide my time between working in general paediatrics and paediatric infectious disease/immunology at the Children’s Hospital in Oxford and vaccine related research within the Oxford Vaccine Group. Research interests are centred around vaccines and vaccine preventable disease in childhood and include the immunology of B-cell responses to vaccines in childhood, B-cell receptor genetics as a tool for understanding immune responses, pneumococcal conjugate vaccines and the epidemiology of invasive bacterial disease and pneumonia in Nepal.
Impact of Vaccination on Haemophilus influenzae Type b Carriage in Healthy Children Less Than 5 Years of Age in an Urban Population in Nepal.
Shrestha S. et al, (2021), J Infect Dis, 224, S267 - S274
Fatal tuberculous meningitis in an infant presenting with seizures in the UK.
Khambati N. et al, (2021), BMJ Case Rep, 14
Persistence of Immunity Following 2-Dose Priming with a 10-Valent Pneumococcal Conjugate Vaccine at 6 and 10 Weeks or 6 and 14 Weeks of Age in Nepalese Toddlers.
Gurung M. et al, (2021), Pediatr Infect Dis J
Corrigendum to 'Responses to an acellular pertussis booster vaccination in children, adolescents, and young and older adults: A collaborative study in Finland, the Netherlands, and the United Kingdom'.
Versteegen P. et al, (2021), EBioMedicine, 68
A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi process.
Harwood R. et al, (2021), Lancet Child Adolesc Health, 5, 133 - 141